New perspectives on rare connective tissue calcifying diseases

Rashdan, Nabil A. and Rutsch, Frank and Kempf, Hervé and Váradi, András and Leftheriotis, Georges (2016) New perspectives on rare connective tissue calcifying diseases. CURRENT OPINION IN PHARMACOLOGY, 28. pp. 14-23. ISSN 1471-4892

Preview

Text 1_s2.0_S147148921630008X_main_u.pdf Available under License Creative Commons Attribution. Download (1MB) | Preview

Abstract

Connective tissue calcifying diseases (CTCs) are characterized by abnormal calcium deposition in connective tissues. CTCs are caused by multiple factors including chronic diseases (Type II diabetes mellitus, chronic kidney disease), the use of pharmaceuticals (e.g. warfarin, glucocorticoids) and inherited rare genetic diseases such as pseudoxanthoma elasticum (PXE), generalized arterial calcification in infancy (GACI) and Keutel syndrome (KTLS). This review explores our current knowledge of these rare inherited CTCs, and highlights the most promising avenues for pharmaceutical intervention. Advancing our understanding of rare inherited forms of CTC is not only essential for the development of therapeutic strategies for patients suffering from these diseases, but also fundamental to delineating the mechanisms underpinning acquired chronic forms of CTC.

Actions (login required)

Edit Item